Associations of Sarcopenia and Its Components With Cardiovascular Risk: Five‐Year Longitudinal Evidence From China Health and Retirement Longitudinal Study

Background Sarcopenia, an age‐related condition, has an unclear association with cardiovascular disease (CVD) risk. We aimed to analyze whether sarcopenia and its individual components are associated with new‐onset CVD in middle‐aged and older adults. Methods and Results Data were derived from the C...

Full description

Saved in:
Bibliographic Details
Main Authors: Yang Chen, Ziyi Zhong, Konstantinos Prokopidis, Ying Gue, Garry McDowell, Yang Liu, Coleen Ditchfield, Muath Alobaida, Bi Huang, Gregory Y. H. Lip
Format: Article
Language:English
Published: Wiley 2025-07-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.124.040099
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839609300418297856
author Yang Chen
Ziyi Zhong
Konstantinos Prokopidis
Ying Gue
Garry McDowell
Yang Liu
Coleen Ditchfield
Muath Alobaida
Bi Huang
Gregory Y. H. Lip
author_facet Yang Chen
Ziyi Zhong
Konstantinos Prokopidis
Ying Gue
Garry McDowell
Yang Liu
Coleen Ditchfield
Muath Alobaida
Bi Huang
Gregory Y. H. Lip
author_sort Yang Chen
collection DOAJ
description Background Sarcopenia, an age‐related condition, has an unclear association with cardiovascular disease (CVD) risk. We aimed to analyze whether sarcopenia and its individual components are associated with new‐onset CVD in middle‐aged and older adults. Methods and Results Data were derived from the China Health and Retirement Longitudinal Study, with sarcopenia defined by the Asian Working Group for Sarcopenia 2019 criteria. The primary outcome was composite CVD, comprising heart disease and stroke. Multivariable Cox proportional hazards regression analysis and Fine–Gray subdistribution hazards models were used to calculate hazard ratios (HRs), subdistribution hazard ratios (SHRs), and 95% CIs. A total of 10 649 participants (mean age 64.5±10.7 years, 47.6% male) were included. During mean follow‐up of 4.60±1.06 years, there were 1649 (15.5%) cases of new‐onset CVD. Possible sarcopenia was linked to increased new‐onset composite CVD risk (HR, 1.21 [95% CI, 1.06–1.37]; SHR, 1.20 [95% CI, 1.05–1.35]), whereas sarcopenia and severe sarcopenia showed no association. Restricted cubic spline analysis revealed that 5‐time chair stand test (5‐CST) was associated with new‐onset composite CVD, with significant sex‐specific interaction (P‐for‐interaction=0.001). Compared with 5‐CST≤9.0 s, higher risk of new‐onset composite CVD was observed in men for 9.0 s<5‐CST≤15.0 s (HR, 1.36 [95% CI, 1.16–1.59]; SHR, 1.34 [95% CI, 1.15–1.56]) and 5‐CST>15.0 s (HR, 2.19 [95% CI, 1.65–2.90]; SHR, 2.00 [95% CI, 1.53–2.63]). Among women, 5‐CST>8.5 s had higher risk of new‐onset composite CVD compared with 5‐CST≤8.5 s (HR, 1.26 [95% CI, 1.09–1.45]; SHR, 1.25 [95% CI, 1.09–1.43]). Conclusion Possible sarcopenia was associated with increased risk of new‐onset composite CVD, suggesting that progression to definite sarcopenia may not parallel cardiovascular risk. Longer 5‐CST was linked to higher risk of new‐onset composite CVD, with sex‐specific association.
format Article
id doaj-art-c6ddcf2c3d0f452a8d43f561b2979c16
institution Matheson Library
issn 2047-9980
language English
publishDate 2025-07-01
publisher Wiley
record_format Article
series Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
spelling doaj-art-c6ddcf2c3d0f452a8d43f561b2979c162025-07-30T11:56:33ZengWileyJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease2047-99802025-07-01141310.1161/JAHA.124.040099Associations of Sarcopenia and Its Components With Cardiovascular Risk: Five‐Year Longitudinal Evidence From China Health and Retirement Longitudinal StudyYang Chen0Ziyi Zhong1Konstantinos Prokopidis2Ying Gue3Garry McDowell4Yang Liu5Coleen Ditchfield6Muath Alobaida7Bi Huang8Gregory Y. H. Lip9Liverpool Centre for Cardiovascular Science University of Liverpool, Liverpool John Moores University and Liverpool Heart &amp; Chest Hospital Liverpool United KingdomLiverpool Centre for Cardiovascular Science University of Liverpool, Liverpool John Moores University and Liverpool Heart &amp; Chest Hospital Liverpool United KingdomLiverpool Centre for Cardiovascular Science University of Liverpool, Liverpool John Moores University and Liverpool Heart &amp; Chest Hospital Liverpool United KingdomLiverpool Centre for Cardiovascular Science University of Liverpool, Liverpool John Moores University and Liverpool Heart &amp; Chest Hospital Liverpool United KingdomLiverpool Centre for Cardiovascular Science University of Liverpool, Liverpool John Moores University and Liverpool Heart &amp; Chest Hospital Liverpool United KingdomLiverpool Centre for Cardiovascular Science University of Liverpool, Liverpool John Moores University and Liverpool Heart &amp; Chest Hospital Liverpool United KingdomDepartment of Medicine for Older People Whiston Hospital, Mersey and West Lancashire Teaching Hospitals NHS Trust Prescot United KingdomLiverpool Centre for Cardiovascular Science University of Liverpool, Liverpool John Moores University and Liverpool Heart &amp; Chest Hospital Liverpool United KingdomLiverpool Centre for Cardiovascular Science University of Liverpool, Liverpool John Moores University and Liverpool Heart &amp; Chest Hospital Liverpool United KingdomLiverpool Centre for Cardiovascular Science University of Liverpool, Liverpool John Moores University and Liverpool Heart &amp; Chest Hospital Liverpool United KingdomBackground Sarcopenia, an age‐related condition, has an unclear association with cardiovascular disease (CVD) risk. We aimed to analyze whether sarcopenia and its individual components are associated with new‐onset CVD in middle‐aged and older adults. Methods and Results Data were derived from the China Health and Retirement Longitudinal Study, with sarcopenia defined by the Asian Working Group for Sarcopenia 2019 criteria. The primary outcome was composite CVD, comprising heart disease and stroke. Multivariable Cox proportional hazards regression analysis and Fine–Gray subdistribution hazards models were used to calculate hazard ratios (HRs), subdistribution hazard ratios (SHRs), and 95% CIs. A total of 10 649 participants (mean age 64.5±10.7 years, 47.6% male) were included. During mean follow‐up of 4.60±1.06 years, there were 1649 (15.5%) cases of new‐onset CVD. Possible sarcopenia was linked to increased new‐onset composite CVD risk (HR, 1.21 [95% CI, 1.06–1.37]; SHR, 1.20 [95% CI, 1.05–1.35]), whereas sarcopenia and severe sarcopenia showed no association. Restricted cubic spline analysis revealed that 5‐time chair stand test (5‐CST) was associated with new‐onset composite CVD, with significant sex‐specific interaction (P‐for‐interaction=0.001). Compared with 5‐CST≤9.0 s, higher risk of new‐onset composite CVD was observed in men for 9.0 s<5‐CST≤15.0 s (HR, 1.36 [95% CI, 1.16–1.59]; SHR, 1.34 [95% CI, 1.15–1.56]) and 5‐CST>15.0 s (HR, 2.19 [95% CI, 1.65–2.90]; SHR, 2.00 [95% CI, 1.53–2.63]). Among women, 5‐CST>8.5 s had higher risk of new‐onset composite CVD compared with 5‐CST≤8.5 s (HR, 1.26 [95% CI, 1.09–1.45]; SHR, 1.25 [95% CI, 1.09–1.43]). Conclusion Possible sarcopenia was associated with increased risk of new‐onset composite CVD, suggesting that progression to definite sarcopenia may not parallel cardiovascular risk. Longer 5‐CST was linked to higher risk of new‐onset composite CVD, with sex‐specific association.https://www.ahajournals.org/doi/10.1161/JAHA.124.0400995‐time chair stand testall‐cause mortalitycardiovascular diseaseheart diseasesarcopeniastroke
spellingShingle Yang Chen
Ziyi Zhong
Konstantinos Prokopidis
Ying Gue
Garry McDowell
Yang Liu
Coleen Ditchfield
Muath Alobaida
Bi Huang
Gregory Y. H. Lip
Associations of Sarcopenia and Its Components With Cardiovascular Risk: Five‐Year Longitudinal Evidence From China Health and Retirement Longitudinal Study
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
5‐time chair stand test
all‐cause mortality
cardiovascular disease
heart disease
sarcopenia
stroke
title Associations of Sarcopenia and Its Components With Cardiovascular Risk: Five‐Year Longitudinal Evidence From China Health and Retirement Longitudinal Study
title_full Associations of Sarcopenia and Its Components With Cardiovascular Risk: Five‐Year Longitudinal Evidence From China Health and Retirement Longitudinal Study
title_fullStr Associations of Sarcopenia and Its Components With Cardiovascular Risk: Five‐Year Longitudinal Evidence From China Health and Retirement Longitudinal Study
title_full_unstemmed Associations of Sarcopenia and Its Components With Cardiovascular Risk: Five‐Year Longitudinal Evidence From China Health and Retirement Longitudinal Study
title_short Associations of Sarcopenia and Its Components With Cardiovascular Risk: Five‐Year Longitudinal Evidence From China Health and Retirement Longitudinal Study
title_sort associations of sarcopenia and its components with cardiovascular risk five year longitudinal evidence from china health and retirement longitudinal study
topic 5‐time chair stand test
all‐cause mortality
cardiovascular disease
heart disease
sarcopenia
stroke
url https://www.ahajournals.org/doi/10.1161/JAHA.124.040099
work_keys_str_mv AT yangchen associationsofsarcopeniaanditscomponentswithcardiovascularriskfiveyearlongitudinalevidencefromchinahealthandretirementlongitudinalstudy
AT ziyizhong associationsofsarcopeniaanditscomponentswithcardiovascularriskfiveyearlongitudinalevidencefromchinahealthandretirementlongitudinalstudy
AT konstantinosprokopidis associationsofsarcopeniaanditscomponentswithcardiovascularriskfiveyearlongitudinalevidencefromchinahealthandretirementlongitudinalstudy
AT yinggue associationsofsarcopeniaanditscomponentswithcardiovascularriskfiveyearlongitudinalevidencefromchinahealthandretirementlongitudinalstudy
AT garrymcdowell associationsofsarcopeniaanditscomponentswithcardiovascularriskfiveyearlongitudinalevidencefromchinahealthandretirementlongitudinalstudy
AT yangliu associationsofsarcopeniaanditscomponentswithcardiovascularriskfiveyearlongitudinalevidencefromchinahealthandretirementlongitudinalstudy
AT coleenditchfield associationsofsarcopeniaanditscomponentswithcardiovascularriskfiveyearlongitudinalevidencefromchinahealthandretirementlongitudinalstudy
AT muathalobaida associationsofsarcopeniaanditscomponentswithcardiovascularriskfiveyearlongitudinalevidencefromchinahealthandretirementlongitudinalstudy
AT bihuang associationsofsarcopeniaanditscomponentswithcardiovascularriskfiveyearlongitudinalevidencefromchinahealthandretirementlongitudinalstudy
AT gregoryyhlip associationsofsarcopeniaanditscomponentswithcardiovascularriskfiveyearlongitudinalevidencefromchinahealthandretirementlongitudinalstudy